Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.440
+0.010 (0.23%)
Sep 8, 2026, 11:54 AM EDT - Market open
Minerva Neurosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 24.65 | 82.3 | 21.36 | 40.91 | 36.09 | 60.76 |
Short-Term Investments | 50.62 | - | - | - | - | - |
Cash & Short-Term Investments | 75.27 | 82.3 | 21.36 | 40.91 | 36.09 | 60.76 |
Cash Growth | 393.62% | 285.27% | -47.79% | 13.35% | -40.59% | 139.60% |
Other Receivables | - | - | - | - | 3.12 | - |
Receivables | - | - | - | - | 3.12 | - |
Prepaid Expenses | 4.37 | 0.7 | 0.81 | 0.99 | 0.85 | 1.35 |
Restricted Cash | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Total Current Assets | 79.73 | 83.1 | 22.27 | 42 | 40.16 | 62.2 |
Property, Plant & Equipment | - | - | 0.01 | 0.01 | 0.02 | - |
Goodwill | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 | 14.87 |
Other Intangible Assets | - | - | - | 0.02 | 0.04 | 0.05 |
Long-Term Deferred Charges | 0.49 | - | - | - | - | - |
Total Assets | 95.09 | 97.97 | 37.14 | 56.9 | 55.09 | 77.12 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.45 | 0.64 | 1.61 | 1.81 | 0.97 | 1.85 |
Accrued Expenses | 2.51 | 1.65 | 1.23 | 1.54 | 0.41 | 0.97 |
Total Current Liabilities | 3.96 | 2.29 | 2.84 | 3.34 | 1.38 | 2.82 |
Long-Term Debt | 60 | 60 | 60 | 82.02 | 73.73 | 66.33 |
Other Long-Term Liabilities | 232.69 | 171.46 | - | - | - | - |
Total Liabilities | 296.65 | 233.76 | 62.84 | 85.36 | 75.11 | 69.15 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 583.43 | 548.05 | 369.68 | 368.36 | 346.79 | 342.68 |
Retained Earnings | -796.74 | -688.8 | -395.38 | -396.82 | -366.81 | -334.7 |
Total Common Equity | -213.3 | -140.75 | -25.69 | -28.46 | -20.02 | 7.98 |
Shareholders' Equity | -201.56 | -135.79 | -25.69 | -28.46 | -20.02 | 7.98 |
Total Liabilities & Equity | 95.09 | 97.97 | 37.14 | 56.9 | 55.09 | 77.12 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 60 | 60 | 60 | 82.02 | 73.73 | 66.33 |
Net Cash (Debt) | 15.27 | 22.3 | -38.64 | -41.1 | -37.64 | -5.57 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.56 | 2.64 | -5.10 | -6.32 | -7.05 | -1.04 |
Filing Date Shares Outstanding | 47.75 | 43.27 | 6.99 | 6.99 | 5.34 | 5.34 |
Total Common Shares Outstanding | 47.23 | 43.27 | 6.99 | 6.99 | 5.34 | 5.34 |
Working Capital | 75.77 | 80.81 | 19.43 | 38.66 | 38.78 | 59.38 |
Book Value Per Share | -4.52 | -3.25 | -3.67 | -4.07 | -3.75 | 1.49 |
Tangible Book Value | -228.17 | -155.62 | -40.56 | -43.34 | -34.94 | -6.94 |
Tangible Book Value Per Share | -4.83 | -3.60 | -5.80 | -6.20 | -6.54 | -1.30 |